These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26608189)

  • 1. A novel, protective role of ursodeoxycholate in bile-induced pancreatic ductal injury.
    Katona M; Hegyi P; Kui B; Balla Z; Rakonczay Z; Rázga Z; Tiszlavicz L; Maléth J; Venglovecz V
    Am J Physiol Gastrointest Liver Physiol; 2016 Feb; 310(3):G193-204. PubMed ID: 26608189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver.
    Benedetti A; Alvaro D; Bassotti C; Gigliozzi A; Ferretti G; La Rosa T; Di Sario A; Baiocchi L; Jezequel AM
    Hepatology; 1997 Jul; 26(1):9-21. PubMed ID: 9214446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrophilic but not hydrophobic bile acids prevent gallbladder muscle dysfunction in acute cholecystitis.
    Xiao ZL; Biancani P; Carey MC; Behar J
    Hepatology; 2003 Jun; 37(6):1442-50. PubMed ID: 12774024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of mitochondrial dysfunction in combined bile acid-induced cytotoxicity: the switch between apoptosis and necrosis.
    Rolo AP; Palmeira CM; Holy JM; Wallace KB
    Toxicol Sci; 2004 May; 79(1):196-204. PubMed ID: 14976352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrially mediated synergistic cell killing by bile acids.
    Rolo AP; Palmeira CM; Wallace KB
    Biochim Biophys Acta; 2003 Jan; 1637(1):127-32. PubMed ID: 12527417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid.
    Combes B; Carithers RL; Maddrey WC; Munoz S; Garcia-Tsao G; Bonner GF; Boyer JL; Luketic VA; Shiffman ML; Peters MG; White H; Zetterman RK; Risser R; Rossi SS; Hofmann AF
    Hepatology; 1999 Jun; 29(6):1649-54. PubMed ID: 10347103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UDCA and CDCA alleviate 17α-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats.
    Li X; Yuan Z; Liu R; Hassan HM; Yang H; Sun R; Zhang L; Jiang Z
    Toxicol Appl Pharmacol; 2016 Nov; 311():12-25. PubMed ID: 27743861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of ursodeoxycholic acid on chenodeoxycholic acid-induced liver injury in hamsters.
    Iwaki T; Ishizaki K; Kinoshita S; Tanaka H; Fukunari A; Tsurufuji M; Imada T
    World J Gastroenterol; 2007 Oct; 13(37):5003-8. PubMed ID: 17854144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture.
    Hillaire S; Ballet F; Franco D; Setchell KD; Poupon R
    Hepatology; 1995 Jul; 22(1):82-7. PubMed ID: 7601437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permeation enhancement of octreotide by specific bile salts in rats and human subjects: in vitro, in vivo correlations.
    Fricker G; Fahr A; Beglinger C; Kissel T; Reiter G; Drewe J
    Br J Pharmacol; 1996 Jan; 117(1):217-23. PubMed ID: 8825366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production.
    Rodrigues CM; Fan G; Wong PY; Kren BT; Steer CJ
    Mol Med; 1998 Mar; 4(3):165-78. PubMed ID: 9562975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel cytotoxic agents from an unexpected source: bile acids and ovarian tumor apoptosis.
    Horowitz NS; Hua J; Powell MA; Gibb RK; Mutch DG; Herzog TJ
    Gynecol Oncol; 2007 Nov; 107(2):344-9. PubMed ID: 17720233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of rat hepatocyte proliferation by bile salts: in vitro and in vivo studies.
    Barone M; Francavilla A; Polimeno L; Ierardi E; Romanelli D; Berloco P; Di Leo A; Panella C
    Hepatology; 1996 May; 23(5):1159-66. PubMed ID: 8621149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of renal disease and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE) by chenodeoxycholic acid.
    Suwannaroj S; Lagoo A; McMurray RW
    Lupus; 2001; 10(8):562-7. PubMed ID: 11530998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different effects of chenodeoxycholic acid and ursodeoxycholic acid on serum lipoprotein concentrations in patients with radiolucent gallstones.
    Leiss O; von Bergmann K
    Scand J Gastroenterol; 1982 Aug; 17(5):587-92. PubMed ID: 7178821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes.
    Qiao L; Yacoub A; Studer E; Gupta S; Pei XY; Grant S; Hylemon PB; Dent P
    Hepatology; 2002 Apr; 35(4):779-89. PubMed ID: 11915023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of ursodeoxycholic acid on N-methylnitrosourea-induced colon carcinogenesis and colonic mucosal telomerase activity in F344 rats.
    Narisawa T; Fukaura Y; Terada K; Sekiguchi H
    J Exp Clin Cancer Res; 1999 Jun; 18(2):259-66. PubMed ID: 10464717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chenodeoxycholic acid and ursodeoxycholic acid administration on acyl-CoA: cholesterol acyltransferase activity in human liver.
    Abate N; Carubbi F; Bozzoli M; Bertolotti M; Farah I; Rosi A; Carulli N
    Ital J Gastroenterol; 1994; 26(6):287-93. PubMed ID: 7949265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acid effects are mediated by ATP release and purinergic signalling in exocrine pancreatic cells.
    Kowal JM; Haanes KA; Christensen NM; Novak I
    Cell Commun Signal; 2015 Jun; 13():28. PubMed ID: 26050734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of bile acids on the postprandial secretion of gut hormones: a randomized crossover study.
    McGlone ER; Malallah K; Cuenco J; Wewer Albrechtsen NJ; Holst JJ; Vincent RP; Ling C; Khan OA; Verma S; Ahmed AR; Walters JRF; Khoo B; Bloom SR; Tan TMM
    Am J Physiol Endocrinol Metab; 2021 Apr; 320(4):E671-E679. PubMed ID: 33459181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.